Molecular mechanisms involved in pulmonary arterial hypertension development

@inproceedings{Drenjan2011MolecularMI,
  title={Molecular mechanisms involved in pulmonary arterial hypertension development},
  author={Ines Drenjan},
  year={2011}
}
  • Ines Drenjan
  • Published 2011
Pulmonary arterial hypertension (PAH) is an elevation in pulmonary arterial pressure, characterized by symptoms of dyspnea, chest pain, decrease in exercise tolerance-fatigue, syncope and, if untreated, PAH leads to right heart failure. In PAH, there is an imbalance between mediators of vasodilation and vasoconstriction (e.g. nitric oxide and prostacycline… CONTINUE READING